Global Multiple Myeloma Drugs Sales Market Report 2016

December 2016 | 115 pages | ID: G44164A7A3AEN
QYResearch

Abstracts

Notes:

Sales, means the sales volume of Multiple Myeloma Drugs

Revenue, means the sales value of Multiple Myeloma Drugs

This report studies sales (consumption) of Multiple Myeloma Drugs in Global market, especially in United States, China, Europe, Japan, focuses on top players in these regions/countries, with sales, price, revenue and market share for each player in these regions, covering

• Amgen
• Johnson & Johnson
• Celgene
• Takeda Pharmaceutical
• Novartis
• Daiichi Sankyo
• Merck
• AB Science
• Teva
• PharmaMar
• Bristol Myers Squibb

Market Segment by Regions, this report splits Global into several key Regions, with sales (consumption), revenue, market share and growth rate of Multiple Myeloma Drugs in these regions, from 2011 to 2021 (forecast), like

• United States
• China
• Europe
• Japan

Split by product Types, with sales, revenue, price and gross margin, market share and growth rate of each type, can be divided into

• Immunomodulatory drugs (IMiDs)
• Proteasome inhibitors
• Chemotherapy
• Histone deacetylase inhibitor (HDAC inhibitor)
• Steroids (corticosteroids)

Split by applications, this report focuses on sales, market share and growth rate of Multiple Myeloma Drugs in each application, can be divided into

• Application 1
• Application 2
• Application 3

Contents

Global Multiple Myeloma Drugs Sales Market Report 2016

1 MULTIPLE MYELOMA DRUGS OVERVIEW

1.1 Product Overview and Scope of Multiple Myeloma Drugs
1.2 Classification of Multiple Myeloma Drugs
  1.2.1 Immunomodulatory drugs (IMiDs)
  1.2.2 Proteasome inhibitors
  1.2.3 Chemotherapy
  1.2.4 Histone deacetylase inhibitor (HDAC inhibitor)
  1.2.5 Steroids (corticosteroids)
1.3 Application of Multiple Myeloma Drugs
  1.3.1 Application
  1.3.2 Application
  1.3.3 Application
1.4 Multiple Myeloma Drugs Market by Regions
  1.4.1 United States Status and Prospect (2011-2021)
  1.4.2 China Status and Prospect (2011-2021)
  1.4.3 Europe Status and Prospect (2011-2021)
  1.4.4 Japan Status and Prospect (2011-2021)
1.5 Global Market Size (Value and Volume) of Multiple Myeloma Drugs (2011-2021)
  1.5.1 Global Multiple Myeloma Drugs Sales and Growth Rate (2011-2021)
  1.5.2 Global Multiple Myeloma Drugs Revenue and Growth Rate (2011-2021)

2 GLOBAL MULTIPLE MYELOMA DRUGS COMPETITION BY MANUFACTURERS, TYPE AND APPLICATION

2.1 Global Multiple Myeloma Drugs Market Competition by Manufacturers
  2.1.1 Global Multiple Myeloma Drugs Sales and Market Share of Key Manufacturers (2011-2016)
  2.1.2 Global Multiple Myeloma Drugs Revenue and Share by Manufacturers (2011-2016)
2.2 Global Multiple Myeloma Drugs (Volume and Value) by Type
  2.2.1 Global Multiple Myeloma Drugs Sales and Market Share by Type (2011-2016)
  2.2.2 Global Multiple Myeloma Drugs Revenue and Market Share by Type (2011-2016)
2.3 Global Multiple Myeloma Drugs (Volume and Value) by Regions
  2.3.1 Global Multiple Myeloma Drugs Sales and Market Share by Regions (2011-2016)
  2.3.2 Global Multiple Myeloma Drugs Revenue and Market Share by Regions (2011-2016)
2.4 Global Multiple Myeloma Drugs (Volume) by Application

3 UNITED STATES MULTIPLE MYELOMA DRUGS (VOLUME, VALUE AND SALES PRICE)

3.1 United States Multiple Myeloma Drugs Sales and Value (2011-2016)
  3.1.1 United States Multiple Myeloma Drugs Sales and Growth Rate (2011-2016)
  3.1.2 United States Multiple Myeloma Drugs Revenue and Growth Rate (2011-2016)
  3.1.3 United States Multiple Myeloma Drugs Sales Price Trend (2011-2016)
3.2 United States Multiple Myeloma Drugs Sales and Market Share by Manufacturers
3.3 United States Multiple Myeloma Drugs Sales and Market Share by Type
3.4 United States Multiple Myeloma Drugs Sales and Market Share by Application

4 CHINA MULTIPLE MYELOMA DRUGS (VOLUME, VALUE AND SALES PRICE)

4.1 China Multiple Myeloma Drugs Sales and Value (2011-2016)
  4.1.1 China Multiple Myeloma Drugs Sales and Growth Rate (2011-2016)
  4.1.2 China Multiple Myeloma Drugs Revenue and Growth Rate (2011-2016)
  4.1.3 China Multiple Myeloma Drugs Sales Price Trend (2011-2016)
4.2 China Multiple Myeloma Drugs Sales and Market Share by Manufacturers
4.3 China Multiple Myeloma Drugs Sales and Market Share by Type
4.4 China Multiple Myeloma Drugs Sales and Market Share by Application

5 EUROPE MULTIPLE MYELOMA DRUGS (VOLUME, VALUE AND SALES PRICE)

5.1 Europe Multiple Myeloma Drugs Sales and Value (2011-2016)
  5.1.1 Europe Multiple Myeloma Drugs Sales and Growth Rate (2011-2016)
  5.1.2 Europe Multiple Myeloma Drugs Revenue and Growth Rate (2011-2016)
  5.1.3 Europe Multiple Myeloma Drugs Sales Price Trend (2011-2016)
5.2 Europe Multiple Myeloma Drugs Sales and Market Share by Manufacturers
5.3 Europe Multiple Myeloma Drugs Sales and Market Share by Type
5.4 Europe Multiple Myeloma Drugs Sales and Market Share by Application

6 JAPAN MULTIPLE MYELOMA DRUGS (VOLUME, VALUE AND SALES PRICE)

6.1 Japan Multiple Myeloma Drugs Sales and Value (2011-2016)
  6.1.1 Japan Multiple Myeloma Drugs Sales and Growth Rate (2011-2016)
  6.1.2 Japan Multiple Myeloma Drugs Revenue and Growth Rate (2011-2016)
  6.1.3 Japan Multiple Myeloma Drugs Sales Price Trend (2011-2016)
6.2 Japan Multiple Myeloma Drugs Sales and Market Share by Manufacturers
6.3 Japan Multiple Myeloma Drugs Sales and Market Share by Type
6.4 Japan Multiple Myeloma Drugs Sales and Market Share by Application

7 GLOBAL MULTIPLE MYELOMA DRUGS MANUFACTURERS ANALYSIS

7.1 Amgen
  7.1.1 Company Basic Information, Manufacturing Base and Competitors
  7.1.2 Multiple Myeloma Drugs Product Type, Application and Specification
    7.1.2.1 Type I
    7.1.2.2 Type II
  7.1.3 Amgen Multiple Myeloma Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
  7.1.4 Main Business/Business Overview
7.2 Johnson & Johnson
  7.2.1 Company Basic Information, Manufacturing Base and Competitors
  7.2.2 115 Product Type, Application and Specification
    7.2.2.1 Type I
    7.2.2.2 Type II
  7.2.3 Johnson & Johnson Multiple Myeloma Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
  7.2.4 Main Business/Business Overview
7.3 Celgene
  7.3.1 Company Basic Information, Manufacturing Base and Competitors
  7.3.2 135 Product Type, Application and Specification
    7.3.2.1 Type I
    7.3.2.2 Type II
  7.3.3 Celgene Multiple Myeloma Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
  7.3.4 Main Business/Business Overview
7.4 Takeda Pharmaceutical
  7.4.1 Company Basic Information, Manufacturing Base and Competitors
  7.4.2 Dec Product Type, Application and Specification
    7.4.2.1 Type I
    7.4.2.2 Type II
  7.4.3 Takeda Pharmaceutical Multiple Myeloma Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
  7.4.4 Main Business/Business Overview
7.5 Novartis
  7.5.1 Company Basic Information, Manufacturing Base and Competitors
  7.5.2 Product Type, Application and Specification
    7.5.2.1 Type I
    7.5.2.2 Type II
  7.5.3 Novartis Multiple Myeloma Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
  7.5.4 Main Business/Business Overview
7.6 Daiichi Sankyo
  7.6.1 Company Basic Information, Manufacturing Base and Competitors
  7.6.2 Million USD Product Type, Application and Specification
    7.6.2.1 Type I
    7.6.2.2 Type II
  7.6.3 Daiichi Sankyo Multiple Myeloma Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
  7.6.4 Main Business/Business Overview
7.7 Merck
  7.7.1 Company Basic Information, Manufacturing Base and Competitors
  7.7.2 Pharmaceuticals Product Type, Application and Specification
    7.7.2.1 Type I
    7.7.2.2 Type II
  7.7.3 Merck Multiple Myeloma Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
  7.7.4 Main Business/Business Overview
7.8 AB Science
  7.8.1 Company Basic Information, Manufacturing Base and Competitors
  7.8.2 Product Type, Application and Specification
    7.8.2.1 Type I
    7.8.2.2 Type II
  7.8.3 AB Science Multiple Myeloma Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
  7.8.4 Main Business/Business Overview
7.9 Teva
  7.9.1 Company Basic Information, Manufacturing Base and Competitors
  7.9.2 Product Type, Application and Specification
    7.9.2.1 Type I
    7.9.2.2 Type II
  7.9.3 Teva Multiple Myeloma Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
  7.9.4 Main Business/Business Overview
7.10 PharmaMar
  7.10.1 Company Basic Information, Manufacturing Base and Competitors
  7.10.2 Product Type, Application and Specification
    7.10.2.1 Type I
    7.10.2.2 Type II
  7.10.3 PharmaMar Multiple Myeloma Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
  7.10.4 Main Business/Business Overview
7.11 Bristol Myers Squibb

8 MULTIPLE MYELOMA DRUGS MAUFACTURING COST ANALYSIS

8.1 Multiple Myeloma Drugs Key Raw Materials Analysis
  8.1.1 Key Raw Materials
  8.1.2 Price Trend of Key Raw Materials
  8.1.3 Key Suppliers of Raw Materials
  8.1.4 Market Concentration Rate of Raw Materials
8.2 Proportion of Manufacturing Cost Structure
  8.2.1 Raw Materials
  8.2.2 Labor Cost
  8.2.3 Manufacturing Process Analysis of Multiple Myeloma Drugs

9 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

9.1 Multiple Myeloma Drugs Industrial Chain Analysis
9.2 Upstream Raw Materials Sourcing
9.3 Raw Materials Sources of Multiple Myeloma Drugs Major Manufacturers in 2015
9.4 Downstream Buyers

10 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

10.1 Marketing Channel
  10.1.1 Direct Marketing
  10.1.2 Indirect Marketing
  10.1.3 Marketing Channel Development Trend
10.2 Market Positioning
  10.2.1 Pricing Strategy
  10.2.2 Brand Strategy
  10.2.3 Target Client
10.3 Distributors/Traders List

11 MARKET EFFECT FACTORS ANALYSIS

11.1 Technology Progress/Risk
  11.1.1 Substitutes Threat
  11.1.2 Technology Progress in Related Industry
11.2 Consumer Needs/Customer Preference Change
11.3 Economic/Political Environmental Change

12 GLOBAL MULTIPLE MYELOMA DRUGS MARKET FORECAST (2016-2021)

12.1 Global Multiple Myeloma Drugs Sales, Revenue Forecast (2016-2021)
12.2 Global Multiple Myeloma Drugs Sales Forecast by Regions (2016-2021)
12.3 Global Multiple Myeloma Drugs Sales Forecast by Type (2016-2021)
12.4 Global Multiple Myeloma Drugs Sales Forecast by Application (2016-2021)

13 APPENDIX

Disclosure Section
Research Methodology
Data Source
China Disclaimer


The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Multiple Myeloma Drugs
Table Classification of Multiple Myeloma Drugs
Figure Global Sales Market Share of Multiple Myeloma Drugs by Type in 2015
Figure Immunomodulatory drugs (IMiDs) Picture
Figure Proteasome inhibitors Picture
Figure Chemotherapy Picture
Figure Histone deacetylase inhibitor (HDAC inhibitor) Picture
Figure Steroids (corticosteroids) Picture
Table Applications of Multiple Myeloma Drugs
Figure Global Sales Market Share of Multiple Myeloma Drugs by Application in 2015
Figure Application 1 Examples
Figure Application 2 Examples
Figure United States Multiple Myeloma Drugs Revenue and Growth Rate (2011-2021)
Figure China Multiple Myeloma Drugs Revenue and Growth Rate (2011-2021)
Figure Europe Multiple Myeloma Drugs Revenue and Growth Rate (2011-2021)
Figure Japan Multiple Myeloma Drugs Revenue and Growth Rate (2011-2021)
Figure Global Multiple Myeloma Drugs Sales and Growth Rate (2011-2021)
Figure Global Multiple Myeloma Drugs Revenue and Growth Rate (2011-2021)
Table Global Multiple Myeloma Drugs Sales of Key Manufacturers (2011-2016)
Table Global Multiple Myeloma Drugs Sales Share by Manufacturers (2011-2016)
Figure 2015 Multiple Myeloma Drugs Sales Share by Manufacturers
Figure 2016 Multiple Myeloma Drugs Sales Share by Manufacturers
Table Global Multiple Myeloma Drugs Revenue by Manufacturers (2011-2016)
Table Global Multiple Myeloma Drugs Revenue Share by Manufacturers (2011-2016)
Table 2015 Global Multiple Myeloma Drugs Revenue Share by Manufacturers
Table 2016 Global Multiple Myeloma Drugs Revenue Share by Manufacturers
Table Global Multiple Myeloma Drugs Sales and Market Share by Type (2011-2016)
Table Global Multiple Myeloma Drugs Sales Share by Type (2011-2016)
Figure Sales Market Share of Multiple Myeloma Drugs by Type (2011-2016)
Figure Global Multiple Myeloma Drugs Sales Growth Rate by Type (2011-2016)
Table Global Multiple Myeloma Drugs Revenue and Market Share by Type (2011-2016)
Table Global Multiple Myeloma Drugs Revenue Share by Type (2011-2016)
Figure Revenue Market Share of Multiple Myeloma Drugs by Type (2011-2016)
Figure Global Multiple Myeloma Drugs Revenue Growth Rate by Type (2011-2016)
Table Global Multiple Myeloma Drugs Sales and Market Share by Regions (2011-2016)
Table Global Multiple Myeloma Drugs Sales Share by Regions (2011-2016)
Figure Sales Market Share of Multiple Myeloma Drugs by Regions (2011-2016)
Figure Global Multiple Myeloma Drugs Sales Growth Rate by Regions (2011-2016)
Table Global Multiple Myeloma Drugs Revenue and Market Share by Regions (2011-2016)
Table Global Multiple Myeloma Drugs Revenue Share by Regions (2011-2016)
Figure Revenue Market Share of Multiple Myeloma Drugs by Regions (2011-2016)
Figure Global Multiple Myeloma Drugs Revenue Growth Rate by Regions (2011-2016)
Table Global Multiple Myeloma Drugs Sales and Market Share by Application (2011-2016)
Table Global Multiple Myeloma Drugs Sales Share by Application (2011-2016)
Figure Sales Market Share of Multiple Myeloma Drugs by Application (2011-2016)
Figure Global Multiple Myeloma Drugs Sales Growth Rate by Application (2011-2016)
Figure United States Multiple Myeloma Drugs Sales and Growth Rate (2011-2016)
Figure United States Multiple Myeloma Drugs Revenue and Growth Rate (2011-2016)
Figure United States Multiple Myeloma Drugs Sales Price Trend (2011-2016)
Table United States Multiple Myeloma Drugs Sales by Manufacturers (2011-2016)
Table United States Multiple Myeloma Drugs Market Share by Manufacturers (2011-2016)
Table United States Multiple Myeloma Drugs Sales by Type (2011-2016)
Table United States Multiple Myeloma Drugs Market Share by Type (2011-2016)
Table United States Multiple Myeloma Drugs Sales by Application (2011-2016)
Table United States Multiple Myeloma Drugs Market Share by Application (2011-2016)
Figure China Multiple Myeloma Drugs Sales and Growth Rate (2011-2016)
Figure China Multiple Myeloma Drugs Revenue and Growth Rate (2011-2016)
Figure China Multiple Myeloma Drugs Sales Price Trend (2011-2016)
Table China Multiple Myeloma Drugs Sales by Manufacturers (2011-2016)
Table China Multiple Myeloma Drugs Market Share by Manufacturers (2011-2016)
Table China Multiple Myeloma Drugs Sales by Type (2011-2016)
Table China Multiple Myeloma Drugs Market Share by Type (2011-2016)
Table China Multiple Myeloma Drugs Sales by Application (2011-2016)
Table China Multiple Myeloma Drugs Market Share by Application (2011-2016)
Figure Europe Multiple Myeloma Drugs Sales and Growth Rate (2011-2016)
Figure Europe Multiple Myeloma Drugs Revenue and Growth Rate (2011-2016)
Figure Europe Multiple Myeloma Drugs Sales Price Trend (2011-2016)
Table Europe Multiple Myeloma Drugs Sales by Manufacturers (2011-2016)
Table Europe Multiple Myeloma Drugs Market Share by Manufacturers (2011-2016)
Table Europe Multiple Myeloma Drugs Sales by Type (2011-2016)
Table Europe Multiple Myeloma Drugs Market Share by Type (2011-2016)
Table Europe Multiple Myeloma Drugs Sales by Application (2011-2016)
Table Europe Multiple Myeloma Drugs Market Share by Application (2011-2016)
Figure Japan Multiple Myeloma Drugs Sales and Growth Rate (2011-2016)
Figure Japan Multiple Myeloma Drugs Revenue and Growth Rate (2011-2016)
Figure Japan Multiple Myeloma Drugs Sales Price Trend (2011-2016)
Table Japan Multiple Myeloma Drugs Sales by Manufacturers (2011-2016)
Table Japan Multiple Myeloma Drugs Market Share by Manufacturers (2011-2016)
Table Japan Multiple Myeloma Drugs Sales by Type (2011-2016)
Table Japan Multiple Myeloma Drugs Market Share by Type (2011-2016)
Table Japan Multiple Myeloma Drugs Sales by Application (2011-2016)
Table Japan Multiple Myeloma Drugs Market Share by Application (2011-2016)
Table Amgen Basic Information List
Table Amgen Multiple Myeloma Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Amgen Multiple Myeloma Drugs Global Market Share (2011-2016)
Table Johnson & Johnson Basic Information List
Table Johnson & Johnson Multiple Myeloma Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Johnson & Johnson Multiple Myeloma Drugs Global Market Share (2011-2016)
Table Celgene Basic Information List
Table Celgene Multiple Myeloma Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Celgene Multiple Myeloma Drugs Global Market Share (2011-2016)
Table Takeda Pharmaceutical Basic Information List
Table Takeda Pharmaceutical Multiple Myeloma Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Takeda Pharmaceutical Multiple Myeloma Drugs Global Market Share (2011-2016)
Table Novartis Basic Information List
Table Novartis Multiple Myeloma Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Novartis Multiple Myeloma Drugs Global Market Share (2011-2016)
Table Daiichi Sankyo Basic Information List
Table Daiichi Sankyo Multiple Myeloma Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Daiichi Sankyo Multiple Myeloma Drugs Global Market Share (2011-2016)
Table Merck Basic Information List
Table Merck Multiple Myeloma Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Merck Multiple Myeloma Drugs Global Market Share (2011-2016)
Table AB Science Basic Information List
Table AB Science Multiple Myeloma Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Figure AB Science Multiple Myeloma Drugs Global Market Share (2011-2016)
Table Teva Basic Information List
Table Teva Multiple Myeloma Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Teva Multiple Myeloma Drugs Global Market Share (2011-2016)
Table PharmaMar Basic Information List
Table PharmaMar Multiple Myeloma Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Figure PharmaMar Multiple Myeloma Drugs Global Market Share (2011-2016)
Table Bristol Myers Squibb Basic Information List
Table Bristol Myers Squibb Multiple Myeloma Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Bristol Myers Squibb Multiple Myeloma Drugs Global Market Share (2011-2016)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Multiple Myeloma Drugs
Figure Manufacturing Process Analysis of Multiple Myeloma Drugs
Figure Multiple Myeloma Drugs Industrial Chain Analysis
Table Raw Materials Sources of Multiple Myeloma Drugs Major Manufacturers in 2015
Table Major Buyers of Multiple Myeloma Drugs
Table Distributors/Traders List
Figure Global Multiple Myeloma Drugs Sales and Growth Rate Forecast (2016-2021)
Figure Global Multiple Myeloma Drugs Revenue and Growth Rate Forecast (2016-2021)
Table Global Multiple Myeloma Drugs Sales Forecast by Regions (2016-2021)
Table Global Multiple Myeloma Drugs Sales Forecast by Type (2016-2021)
Table Global Multiple Myeloma Drugs Sales Forecast by Application (2016-2021)